CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.840
-0.120 (-4.05%)
At close: Mar 12, 2026, 4:00 PM EDT
2.820
-0.020 (-0.70%)
After-hours: Mar 12, 2026, 7:41 PM EDT
CNS Pharmaceuticals Employees
As of December 31, 2024, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,614,226
Market Cap
1.76M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 5 | 0 | - | 4 | 1 |
| Dec 31, 2023 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2022 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2021 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2020 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| Scinai Immunotherapeutics | 31 |
| Lyra Therapeutics | 30 |
| Virax Biolabs Group | 19 |
| Ensysce Biosciences | 8 |
| Enveric Biosciences | 6 |
| Adial Pharmaceuticals | 5 |
| 60 Degrees Pharmaceuticals | 3 |
CNSP News
- 1 day ago - CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline - Accesswire
- 10 days ago - CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team - Accesswire
- 23 days ago - CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation - Accesswire
- 6 weeks ago - CNS Pharmaceuticals Issues Letter to Shareholders - Accesswire
- 3 months ago - CNS Pharmaceuticals Announces CEO Transition - Accesswire
- 4 months ago - CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 4 months ago - CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 4 months ago - CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting - Accesswire